Remus Pharmaceuticals Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

1.47

1.09

1.00

0.01

0.01

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

80.59

18.05

5.43

3.04

2.01

Loan funds

Secured loans

1.44

7.94

0.19

0.28

0.36

Unsecured loans

-

-

-

-

-

Total

83.50

27.08

6.62

3.33

2.38

Uses of funds

Fixed assets

Gross block

4.11

3.49

0.79

0.72

0.65

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1.82

0.94

0.48

0.33

0.15

Net block

2.29

2.54

0.31

0.39

0.50

Capital work-in-progress

0.01

0.02

-

-

-

Investments

43.12

20.62

3.07

0.07

-

Net current assets

Current assets, loans & advances

52.63

11.48

12.53

10.59

4.80

Less : current liabilities & provisions

14.55

7.58

9.29

7.72

2.92

Total net current assets

38.08

3.90

3.25

2.87

1.88

Miscellaneous expenses not written

-

-

-

-

-

Total

83.50

27.08

6.62

3.33

2.38

Notes:

Book value of unquoted investments

43.12

20.62

3.07

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

75.97

94.36

-

-

-

Number of equity sharesoutstanding (Lacs)

14.73

10.85

10.00

0.10

0.10